DexCom (DXCM)
(Delayed Data from NSDQ)
$70.43 USD
-1.49 (-2.07%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $70.35 -0.08 (-0.11%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth C Momentum D VGM
Income Statements
Fiscal Year end for DexCom, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3,622 | 2,910 | 2,449 | 1,927 | 1,476 |
Cost Of Goods | 1,333 | 1,027 | 768 | 647 | 545 |
Gross Profit | 2,289 | 1,883 | 1,681 | 1,280 | 932 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,691 | 1,492 | 1,415 | 981 | 789 |
Income After Depreciation & Amortization | 598 | 391 | 266 | 300 | 142 |
Non-Operating Income | 113 | 18 | 8 | 10 | 22 |
Interest Expense | 0 | 19 | 100 | 85 | 60 |
Pretax Income | 710 | 391 | 174 | 225 | 104 |
Income Taxes | 169 | 50 | 19 | -269 | 3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 542 | 341 | 155 | 494 | 101 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 542 | 341 | 155 | 494 | 101 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 784 | 547 | 368 | 367 | 191 |
Depreciation & Amortization (Cash Flow) | 186 | 156 | 102 | 67 | 49 |
Income After Depreciation & Amortization | 598 | 391 | 266 | 300 | 142 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 425.50 | 427.50 | 400.40 | 390.00 | 369.20 |
Diluted EPS Before Non-Recurring Items | 1.52 | 0.87 | 0.67 | 0.78 | 0.46 |
Diluted Net EPS (GAAP) | 1.30 | 0.82 | 0.39 | 1.27 | 0.28 |
Fiscal Year end for DexCom, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1,004.30 | 921.00 | 1,034.50 | 975.00 | 871.30 |
Cost Of Goods | 377.60 | 359.10 | 377.90 | 351.70 | 324.90 |
Gross Profit | 626.70 | 561.90 | 656.60 | 623.30 | 546.40 |
SG&A, R&D, and Dept/Amort Expenses | 468.70 | 460.80 | 439.70 | 417.80 | 418.30 |
Income After SG&A, R&D, and Dept/Amort Expenses | 158.00 | 101.10 | 216.90 | 205.50 | 128.10 |
Non-Operating Income | 29.80 | 31.40 | 78.80 | 34.90 | 37.10 |
Interest Expense | 0.00 | 0.00 | -10.50 | 0.00 | 5.90 |
Pretax Income | 187.80 | 132.50 | 246.20 | 240.40 | 159.30 |
Income Taxes | 44.30 | -13.90 | -10.10 | 119.70 | 43.40 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 143.50 | 146.40 | 256.30 | 120.70 | 115.90 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 143.50 | 146.40 | 256.30 | 120.70 | 115.90 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 416.80 | 416.70 | 415.90 | 426.80 | 431.50 |
Diluted EPS Before Non-Recurring Items | 0.43 | 0.32 | 0.50 | 0.50 | 0.34 |
Diluted Net EPS (GAAP) | 0.35 | 0.36 | 0.61 | 0.29 | 0.28 |